Clinical Trial

Virtual Reality Versus Intravenous Dexmedetomidine on Maternal Anxiety, Stress, Hemodynamics, and Neonatal Outcomes During Cesarean Section

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated January 21, 2026 (before its estimated July 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
This study aims to compare the efficacy of intravenous dexmedetomidine infusion versus virtual reality (VR) in reducing maternal anxiety, stress, and hemodynamic instability during cesarean section and their effects on neonatal outcome as respiration and heart rate.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-01-07.
Status change: Not Yet Recruiting → Recruiting 2026-01-17
Trial Details
NCT Number NCT07343843
Lead Sponsor Benha University
Conditions Virtual Reality, Dexmedetomidine, Maternal Anxiety, Stress, Hemodynamics, Neonatal Outcomes, Cesarean Section
Enrollment 52 participants
Start Date 2026-01-17
Primary Completion 2026-07-01 (estimated)
Study Completion 2026-07-01 (estimated)
Updated on ClinicalTrials.gov 2026-01-21